Durability of bleeding protection and factor ix activity in those with and without aav5 neutralising antibodies in the phase 3 hope-b trial of etranacogene dezaparvovec for haemophilia b
HAEMOPHILIA(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要